Currently trading under a dime. $1.00 in six months.
AMBS is another Amgen in its infancy.
Follow the company on Twitter: @AmarantusBio ...... 8,437 followers
Expecting major news soon. Up trend is firmly in place.
Interesting and dverse group of followers on Twitter. Check it out. @AmarantusBio
Gerald will be presenting there.
Sep 8, 2013 - Sep 10, 2013
New York, New York
MANF is a drug that will have "orphan indication" to treat more than 30 diseases.
Know what you own.
There's a number of biotechs with substantially less potential than AMBS with market caps ten times AMBS's current market cap.